Vaidya Sane Ayurved Laboratories P/E Ratio
Current P/E Ratio
35.54
High Valuation
Very High - High growth expectations or significantly overvalued
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) P/E ratio is 35.54 (High), EPS (TTM) ₹6.76, current price ₹ on None — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see MADHAVBAUG screener.
Current Valuation Metrics
P/E Ratio
35.54
Current Price
₹
EPS (TTM)
₹6.76
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.75
Sector Median
27.43
Sector Rank
#11 of 192
Sector Percentile
5.7%
Earnings Breakdown (TTM)
TTM EPS
₹8.32
Sept 2023
₹1.12
Jun 2023
₹2.60
MADHAVBAUG P/E Ratio — Valuation Signal & Historical Context
Vaidya Sane Ayurved Laboratories P/E 35.54 — signal: Overvalued. Analyse MADHAVBAUG shareholding pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 35.54, suggesting caution for new investments
- Trading at discount to sector average PE of 53.75
MADHAVBAUG vs Healthcare Peers — P/E Ratio Comparison
Vaidya Sane Ayurved Laboratories P/E 35.54 vs Healthcare average 53.75, median 27.43 — range 1.03–1007.14.
Sector Average
53.75
Sector Median
27.43
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.44 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹68 | Low |
| Par Drugs & Chemical | PAR | 8.09 | ₹113 | Low |
| Galaxy Medicare | GML | 8.65 | ₹29 | Low |